Yearly Archives: 2021

Novo Nordisk (NVO-NYSE, $99.48) Indicates Fast Launch of Wegovy, for Weight Loss.

From the second quarter, 2021 conference call: “The US launch of Wegovy has been extraordinarily fast. Following a six-month FDA review, Wegovy was approved on June 4, launched on June 10 and available to-or excuse me yes, available to patients

Posted in Open Blog

Global Market for mRNA Covid-19 Vaccines may be Larger than Anticipated, Given the Real World Impotence of “Not-mRNA” Vaccines.

Recent Brazilian allegations of financial irregularities pertaining to the purchase order of Bharat Pharmaceuticals covid-19 vaccine are troubling. The Bharat order has been cancelled. https://www.theguardian.com/world/2021/jun/29/brazil-cancels-covaxin-contract-after-serious-accusations-of-irregularities Allegations that Bharat diverted approximately 15% of the contract price, on a 20 million dose

Posted in Open Blog

Gnostic Capital Large Cap Global Portfolio Return of 17.5% for the Quarter Ended 06/30/2021.

For the quarter ended June 30th, 2021, the DJIA advanced by 4.5%, the S&P 500 increased by 8.2% and the NASDAQ Composite Index appreciated by 10.8%. US M2 money supply grew by 3.8% in the quarter. By way of comparison,

Posted in Open Blog

EBAY (EBAY-NASD, $67.90) may Ultimately Spin Off the Holding in Adevinta (ADSB-Norway, $20.50 US) in the Form of a Distribution.

The pending sale of the Ebay online classified business seeks to monetize an asset. EBAy will receive 540 million shares of Adevinta, presently valued at $20.50 per share. With 681 mmillion shares of Ebay outstanding, this represents approximately .79 shares

Posted in Portfolio Model Subscription

PayPal Holdings (PYPL-NYSE, $285.32) Announces Largest fee Increase in the Corporation’s History. My Accretion Revision is Noteworthy.

https://finance.yahoo.com/news/paypal-overhauls-u-rates-payments-160233113.html

Posted in Portfolio Model Subscription
Recent Comments